Protocolo de evaluación y manejo de efectos adversos del tratamiento esteroideo

  1. Baena Nieto, G. 1
  2. Vílchez López, F. J. 2
  3. Cornejo Domínguez, J. M. 2
  1. 1 Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital de Jerez, Jerez de la Frontera, Cádiz, España
  2. 2 Hospital Puerta del Mar, Cádiz, España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2020

Issue Title: Enfermedades endocrinológicas y metabólicas (VII)Patología suprarrenal

Series: 13

Issue: 19

Pages: 1109-1112

Type: Article

DOI: 10.1016/J.MED.2020.10.017 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

The use of corticosteroids is becoming more and more widespread in clinical practice. They are synthetic analogs of steroid hormones and show a mineralocorticoid and glucocorticoid effect varying in duration and intensity. Its side effects are frequent and of clinical relevance and depend on the dose and cumulative duration of the corticosteroid administered. In patients treated with corticosteroids, two aspects have to be evaluated: side effects of corticosteroids and the state of the adrenal axis. Both procedures require specific study protocols. Being the use of corticosteroids a frequent practice in clinical activity, close monitoring of the patients by expert professionals to identify both the activity of the adrenal axis and the presence of side effects is required.

Bibliographic References

  • L. Buckley , M.B. Humphrey Glucocorticoid-induced osteoporosis N Engl J Med., 379 (2018), pp. 2547-2556
  • L. Buckley , G. Guyatt, H.A. Fink, M. Cannon, J. Grossman, K.E. Hansen, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheumatol., 69 (2017), pp. 1521-1537
  • D. Liu , A. Ahmet, L. Ward, P. Krishnamoorthy, E.D. Mandelcorn, R. Leigh, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy Allergy Asthma Clin Immunol., 9 (2013), p. 30
  • A. Roberts , J. James, K. Dhatariya Managament of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group Diabet Med., 35 (2018), pp. 1011-1017
  • A. Radhakutty , M. Burt Management of endocrine disease: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia Eur J Endocrinol., 179 (2018), pp. 207-218
  • G.E. Umpierrez , R. Hellman, M.T. Korytkwski, M. Kosiborod, G.A. Maynard, V.M. Montori, et al. Management of hypergycemia in hospitalized patients in non critical care setting: and Endocrine Society Clinical Practice Guideline J Clin Endocr., 97 (2012), pp. 16-38
Data source: Dialnet